Cargando…

The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy

Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening infectious complications and should therefore be considered a medical emergency. Patients presenting with FN are routinely subjected to carefu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecha, Judith A. E. M., Raber-Durlacher, Judith E., Laheij, Alexa M. G. A., Westermann, Anneke M., Epstein, Joel B., de Lange, Jan, Smeele, Ludi E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726710/
https://www.ncbi.nlm.nih.gov/pubmed/31222393
http://dx.doi.org/10.1007/s00520-019-04925-8
_version_ 1783449131902042112
author Zecha, Judith A. E. M.
Raber-Durlacher, Judith E.
Laheij, Alexa M. G. A.
Westermann, Anneke M.
Epstein, Joel B.
de Lange, Jan
Smeele, Ludi E.
author_facet Zecha, Judith A. E. M.
Raber-Durlacher, Judith E.
Laheij, Alexa M. G. A.
Westermann, Anneke M.
Epstein, Joel B.
de Lange, Jan
Smeele, Ludi E.
author_sort Zecha, Judith A. E. M.
collection PubMed
description Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening infectious complications and should therefore be considered a medical emergency. Patients presenting with FN are routinely subjected to careful history taking and physical examination including X-rays and microbiological evaluations. Nevertheless, an infection is documented clinically in only 20–30% of cases, whereas a causative microbial pathogen is not identified in over 70% of FN cases. The oral cavity is generally only visually inspected. Although it is recognized that ulcerative oral mucositis may be involved in the development of FN, the contribution of infections of the periodontium, the dentition, and salivary glands may be underestimated. These infections can be easily overlooked, as symptoms and signs of inflammation may be limited or absent during neutropenia. This narrative review is aimed to inform the clinician on the potential role of the oral cavity as a potential source in the development of FN. Areas for future research directed to advancing optimal management strategies are discussed.
format Online
Article
Text
id pubmed-6726710
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-67267102019-09-17 The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. Epstein, Joel B. de Lange, Jan Smeele, Ludi E. Support Care Cancer Review Article Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening infectious complications and should therefore be considered a medical emergency. Patients presenting with FN are routinely subjected to careful history taking and physical examination including X-rays and microbiological evaluations. Nevertheless, an infection is documented clinically in only 20–30% of cases, whereas a causative microbial pathogen is not identified in over 70% of FN cases. The oral cavity is generally only visually inspected. Although it is recognized that ulcerative oral mucositis may be involved in the development of FN, the contribution of infections of the periodontium, the dentition, and salivary glands may be underestimated. These infections can be easily overlooked, as symptoms and signs of inflammation may be limited or absent during neutropenia. This narrative review is aimed to inform the clinician on the potential role of the oral cavity as a potential source in the development of FN. Areas for future research directed to advancing optimal management strategies are discussed. Springer Berlin Heidelberg 2019-06-20 2019 /pmc/articles/PMC6726710/ /pubmed/31222393 http://dx.doi.org/10.1007/s00520-019-04925-8 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Zecha, Judith A. E. M.
Raber-Durlacher, Judith E.
Laheij, Alexa M. G. A.
Westermann, Anneke M.
Epstein, Joel B.
de Lange, Jan
Smeele, Ludi E.
The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
title The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
title_full The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
title_fullStr The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
title_full_unstemmed The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
title_short The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
title_sort impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726710/
https://www.ncbi.nlm.nih.gov/pubmed/31222393
http://dx.doi.org/10.1007/s00520-019-04925-8
work_keys_str_mv AT zechajudithaem theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT raberdurlacherjudithe theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT laheijalexamga theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT westermannannekem theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT epsteinjoelb theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT delangejan theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT smeeleludie theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT zechajudithaem impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT raberdurlacherjudithe impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT laheijalexamga impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT westermannannekem impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT epsteinjoelb impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT delangejan impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy
AT smeeleludie impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy